NAFDAC's Adeyeye Calls for Global Support in Vaccine Production

Prof. Mojisola Adeyeye, the Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), has solicited support from international partners to establish vaccine manufacturing facilities in Nigeria. This initiative aims to help NAFDAC achieve the World Health Organisation (WHO) Maturity Level 4 for vaccine lot release.
Adeyeye made this appeal during the 8th Nigeria Pharma Manufacturers’ Expo in Lagos, organized by the Pharmaceutical Manufacturing Group of Manufacturers Association of Nigeria (PMG-MAN) and PGE Expo Pvt Ltd. She acknowledged the support received for reaching Maturity Level 3 and urged partners to contribute to fill-and-finish modular vaccine manufacturing.
Adeyeye emphasized that Nigeria has the potential for local vaccine production and praised President Bola Tinubu for the Executive Order 2024, which she described as transformative for local manufacturers. She also noted significant improvements in quality and a reduction in imports due to NAFDAC's initiatives, including a Good Manufacturing Practice (GMP) Roadmap audit.
Plus234Feed summary based on reporting from This Day. Read the original report below.
Read full article
Continue on This Day
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories

NAFDAC's Adeyeye Calls for Local Vaccine Manufacturing Support

NAFDAC Reports 70% Cut in Drug Imports, Boosts Local Manufacturing

NAFDAC DG Links Counterfeit Medicine Crisis to Gaps

NAFDAC Addresses Fake Product Concerns in Nigeria

Nigeria Aims for 70% Local Drug Production by 2030

Nigeria Aims for 70% Local Drug Production by 2026
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.









